Evaluation of eligibility criteria in advanced prostate cancer clinical trials based on ASCO-FCR recommendations.

被引：0
|
作者：
Feng, Matthew I.
Prajapati, Sweta R.
Castro, Daniela V.
Lee, Kyle O.
Chan, Elyse H.
Sehgal, Ishaan
Patel, Jalen
O'Dell, Anna
Zengin, Zeynep Busra
Li, Xiaochen
Chehrazi-Raffle, Alex
Dizman, Nazli
Tripathi, Abhishek
Rock, Adam
Liu, Sandy
Mercier, Benjamin D.
Meza, Luis A.
Philip, Errol James
Dorff, Tanya B.
Pal, Sumanta Monty
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] Yale Univ, Sch Med, New Haven, CT USA
[4] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA
[5] City Hope Orange Country Lennar Fdn Canc Ctr, Irvine, CA USA
[6] Univ Calif San Francisco, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
34
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Call to action: overcoming enrollment disparities in cancer clinical trials with modernized eligibility criteria
    Riner, Andrea N.
    Freudenberger, Devon C.
    Herremans, Kelly M.
    Vudatha, Vignesh
    Neal, Daniel W.
    George, Thomas J.
    Trevino, Jose G.
    JNCI CANCER SPECTRUM, 2023, 7 (02)
  • [42] Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non-Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations
    Harvey, R. Donald
    Bruinooge, Suanna S.
    Chen, Li
    Garrett-Mayer, Elizabeth
    Rhodes, Whitney
    Stepanski, Edward
    Uldrick, Thomas S.
    Ison, Gwynn
    Khozin, Sean
    Rubinstein, Wendy S.
    Schenkel, Caroline
    Miller, Robert S.
    Komatsoulis, George A.
    Schilsky, Richard L.
    Kim, Edward S.
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2430 - 2434
  • [43] Knowledge Services Using Rule-Based Formalization for Eligibility Criteria of Clinical Trials
    Huang, Zhisheng
    Hu, Qing
    ten Teije, Annette
    van Harmelen, Frank
    Ait-Mokhtar, Salah
    HEALTH INFORMATION SCIENCE, HIS 2016, 2016, 10038 : 49 - 61
  • [44] Clinical Significance of Eligibility Criteria Determined by the SPIRITS Trial in Patients with Advanced Gastric Cancer
    Satake, Souichi
    Arigami, Takaaki
    Matsushita, Daisuke
    Okubo, Keishi
    Shimonosono, Masataka
    Sasaki, Ken
    Tsuruda, Yusuke
    Tanabe, Kan
    Mori, Shinichiro
    Yanagita, Shigehiro
    Uenosono, Yoshikazu
    Nakajo, Akihiro
    Kurahara, Hiroshi
    Ohtsuka, Takao
    ONCOLOGY, 2023, 101 (01) : 12 - 21
  • [45] Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group
    Bubley, GJ
    Carducci, M
    Dahut, W
    Dawson, N
    Daliani, D
    Eisenberger, M
    Figg, WD
    Freidlin, B
    Halabi, S
    Hudes, G
    Hussain, M
    Kaplan, R
    Myers, C
    Oh, W
    Petrylak, DP
    Reed, E
    Roth, B
    Sartor, O
    Scher, H
    Simons, J
    Sinibaldi, V
    Small, EJ
    Smith, MR
    Trump, DL
    Vollmer, R
    Wilding, G
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3461 - 3467
  • [46] A Method for Matching Patients to Advanced Prostate Cancer Clinical Trials
    Wagholikar, Amol S.
    Anthony Nguyen
    Fung, Maggie
    ELECTRONIC JOURNAL OF HEALTH INFORMATICS, 2014, 8 (01):
  • [47] Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials
    Riner, Andrea N.
    Girma, Selamawit
    Vudatha, Vignesh
    Mukhopadhyay, Nitai
    Skoro, Nevena
    Gal, Tamas S.
    Freudenberger, Devon C.
    Herremans, Kelly M.
    George, Thomas J.
    Trevino, Jose G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (20) : 2193 - +
  • [48] Development of criteria to monitor the occurrence of prostate cancer in testosterone clinical trials
    Snyder, PJ
    PHARMACOLOGY, BIOLOGY, AND CLINICAL APPLICATIONS OF ANDROGENS: CURRENT STATUS AND FUTURE PROSPECTS, 1996, : 143 - 154
  • [49] The Prostate Cancer Clinical Trials Working Group (PCCTWG) consensus criteria for phase II clinical trials for castration-resistant prostate cancer
    Scher, H. I.
    Halabi, S.
    Tannock, I.
    Morris, M.
    Higano, C.
    Kelly, W.
    Sternberg, C.
    Eisenberger, M.
    Martin, A.
    Hussain, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Scott R. Evans
    Dianne Paraoan
    Jane Perlmutter
    Sudha R. Raman
    John J. Sheehan
    Zachary P. Hallinan
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 545 - 552
12345